This is a preview of subscription content, log in via an institution to check access.
Notes
incremental cost-effectiveness ratio
Reference
Koleva-Kolarova RG, et al. Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study. Oncotarget : 13 Apr 2018. Available from: URL: https://doi.org/10.18632/oncotarget.24869
Rights and permissions
About this article
Cite this article
PET/CT cost effective for selecting targeted treatment in breast cancer. PharmacoEcon Outcomes News 803, 20 (2018). https://doi.org/10.1007/s40274-018-4947-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4947-6